INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old Read more about INAVAC Vaccine Phase III (Immunobridging Study) in Healthy Population Aged 12 to 17 Years Old
Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID Read more about Neurobiological Underpinnings of Neuropsychological Consequences in Long COVID
Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19). Read more about Calcifediol in the Treatment of SARS-CoV-2 Disease (COVID-19).
Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2 Read more about Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2
COVID-19 Booster Study in Healthy Adults in Australia Read more about COVID-19 Booster Study in Healthy Adults in Australia
UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects Read more about UNAIR Inactivated COVID-19 Vaccine INAVAC as Heterologue Booster (Immunobridging Study) in Adolescent Subjects
